NCT01692236|Terminated
Brain Imaging for HIV-Associated Thinking and Mood Disorders
Neurovascular Magnetic Resonance Imaging in the Assessment of HIV-Associated Neurocognitive Disorders
Loading search results
Neurovascular Magnetic Resonance Imaging in the Assessment of HIV-Associated Neurocognitive Disorders
Sponsor study identifier
Secondary identifiers
observational
84
1 country
1
Study Start
September 13, 2012
Date type not reportedThis date has not been verified as actual or estimated.
Primary Completion
Not reported
Date not reportedStudy Completion
April 4, 2018
Date type not reportedThis date has not been verified as actual or estimated.
Background: \- Human immunodeficiency virus (HIV) infection appears to cause problems with blood vessel function. These problems may add to some thinking and mood disorders found in people with HIV infection. Researchers want to evaluate HIV infected patients to see if blood vessel function contributes to thinking and mood disorders, such as early dementia and depression. To do so, they will compare study results between people with and people without HIV infection. Objectives:
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
April 4, 2018
Date type not reportedThis date has not been verified as actual or estimated.
Click on a node to explore related trials.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
September 13, 2012
Date type not reportedThis date has not been verified as actual or estimated.
September 20, 2012
Actual (reported)September 25, 2012
Actual (reported)April 4, 2018
Date type not reportedThis date has not been verified as actual or estimated.
Neuropsychologic testing scores
1-6 years
Serum biomarkers of cardiovascular disease and inflammation
1-6 years
MRI brain and vascular findings
1-6 years
National Institutes of Health Clinical Center, 9000 Rockville Pike
Bethesda, Maryland, 20892, United States
Connor M. Human immunodeficiency virus (HIV) and stroke: targets for intervention. Infect Disord Drug Targets. 2010 Apr;10(2):76-83. doi: 10.2174/187152610790963483.
Highleyman L. Mortality trends: toward a new definition of AIDS? BETA. 2005 Winter;17(2):18-28.
Holtgrave DR. Causes of the decline in AIDS deaths, United States, 1995-2002: prevention, treatment or both? Int J STD AIDS. 2005 Dec;16(12):777-81. doi: 10.1258/095646205774988109.
Avindra Nath, M.D.
National Institute of Neurological Disorders and Stroke (NINDS)
84 participants (actual enrollment reported by the registry).
First Submitted
September 20, 2012
First Posted
September 25, 2012
Study Start
September 13, 2012
Date type not reportedThis date has not been verified as actual or estimated.
Body Image in Youth With HIV
Contact the study team to confirm eligibility.
Study Completion
April 4, 2018
Date type not reportedThis date has not been verified as actual or estimated.
Last Updated
December 5, 2019
Record last verified: 2018-04-04
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved: